Category Archives: Expired

Thursday, February 10, 2022 6:30 pm – 8:00 pm EST With featured speaker: Scott Newsome, DO, MSCS, FAAN, FANAAssociate Professor of NeurologyDirector, Neurosciences Consultation and Infusion CenterDirector, Stiff Person Syndrome CenterCo-Director, Multiple Sclerosis Experimental Therapeutics ProgramCo-Director, Johns Hopkins Neuroimmunology Clinical Fellowship ProgramJohns Hopkins Hospital This timely live webinar will provide highlights from CMSC’s annual meeting, including …

Continue reading “ForuMS: Highlights from the 2021 CMSC Annual Meeting”

DATE OF RELEASE/EXPIRATION The enduring material will be available from September 10, 2021 to September 10, 2022 Jointly provided by Consortium of Multiple Sclerosis Centers (CMSC) and PlatformQ Health Education, LLC (PQHE). CREDIT AVAILABLE Physicians – 0.25 AMA PRA Category 1 Credit(s)™Nurses – 0.25 contact hours of nursing continuing professional development (NCPD)Pharmacists – 0.25 contact …

Continue reading “CIS: Treating or Not Treating and with What?”

DATE OF RELEASE/EXPIRATION The enduring material will be available from September 10, 2021 to September 10, 2022 Jointly provided by Consortium of Multiple Sclerosis Centers (CMSC) and PlatformQ Health Education, LLC (PQHE). CREDIT AVAILABLE Physicians – 0.25 AMA PRA Category 1 Credit(s)™Nurses – 0.25 contact hours of nursing continuing professional development (NCPD)Pharmacists – 0.25 contact …

Continue reading “Young Latina MS Patient and Family Planning”

DATE OF RELEASE/EXPIRATION The enduring material will be available from September 10, 2021 to September 10, 2022 Jointly provided by Consortium of Multiple Sclerosis Centers (CMSC) and PlatformQ Health Education, LLC (PQHE). CREDIT AVAILABLE Physicians – 0.25 AMA PRA Category 1 Credit(s)™Nurses – 0.25 contact hours of nursing continuing professional development (NCPD)Pharmacists – 0.25 contact …

Continue reading “MANAGEMENT OF MS IN AFRICAN AMERICANS/BLACKS”

DATE OF RELEASE/EXPIRATION The enduring material will be available from September 10, 2021 to September 10, 2022 Jointly provided by Consortium of Multiple Sclerosis Centers (CMSC) and PlatformQ Health Education, LLC (PQHE). CREDIT AVAILABLE Physicians – 0.5 AMA PRA Category 1 Credit(s)™Nurses – 0.5 contact hours of nursing continuing professional development (NCPD)Pharmacists – 0.5 contact …

Continue reading “TREATMENT APPROACHES IN MS: CRITERIA FOR DECISION MAKING”

DATE OF RELEASE/EXPIRATION The enduring material will be available from August 27, 2021 to September 10, 2022 Jointly provided by Consortium of Multiple Sclerosis Centers (CMSC) and PlatformQ Health Education, LLC (PQHE). CREDIT AVAILABLE Physicians – 1.0 AMA PRA Category 1 Credit(s)™Nurses – 1.0 contact hours of nursing continuing professional development (NCPD)Pharmacists – 1.0 contact …

Continue reading “RACIAL AND GENETIC IMPLICATIONS FOR MS TREATMENT SELECTION”

Released on: December 31, 2021 Deadline extended to: June 30, 2023 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education.   This activity is supported by an independent grant from Alexion Pharmaceuticals. Credit Available Physicians— maximum of 0.75 AMA PRA Category 1 Credit(s)™ Nurses— maximum of 0.75 contact …

Continue reading “Neuromyelitis Optica Spectrum Disorder: Modern Approaches to Diagnosis and Treatment”

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 1: FUNDAMENTALS OF CANNABIS REISSUANCE DATE: October 31, 2021 VALID FOR CREDIT THROUGH: October 31, 2022 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. However, numerous surveys indicate that …

Continue reading “Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis”

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 2: CANNABIS AS AN HERBAL MEDICINE – EFFICACY/SIDE EFFECT CONSIDERATIONS AND CASE STUDIES REISSUANCE DATE: October 31, 2021 VALID FOR CREDIT THROUGH: October 31, 2022 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with …

Continue reading “Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies”

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 3: PHARMACOLOGY AND INTERACTIONS, TRIAL DATA, DMTs, AND CASE STUDIES REISSUANCE DATE: October 31, 2021 VALID FOR CREDIT THROUGH: October 31, 2022 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use …

Continue reading “Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies”